Cynthia Campbell, PhD

TitleAssociate Professor
SchoolUCSF School of Medicine
Address3333 California Street
San Francisco CA 94118
vCardDownload vCard

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Integrating Addiction Research in Health Systems: The Addiction Research Network
    NIH/NIDA UG1DA040314Sep 1, 2015 - May 31, 2020
    Role: Principal Investigator
    Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence
    NIH/NIDA R01DA036603Sep 15, 2014 - Aug 31, 2018
    Role: Principal Investigator
    The Impact of Health Care Reform on Addiction and HIV Services
    NIH/NIDA R33DA035645May 1, 2013 - Apr 30, 2018
    Role: Co-Principal Investigator
    The Impact of Health Care Reform on Addiction and HIV Services
    NIH/NIDA R21DA035645May 1, 2013 - Apr 30, 2014
    Role: Co-Principal Investigator
    High Deductible Health Plans: Substance Abuse Service Use and Cost Trajectories
    NIH/NIDA R01DA030438Sep 15, 2011 - Aug 31, 2014
    Role: Principal Investigator
    Alcohol Trajectories and Service Use in Young Adults: Nine Years Post Treatment
    NIH/NIAAA R01AA018142May 20, 2010 - Apr 30, 2013
    Role: Principal Investigator
    Patients with Alcohol Problems and Chronic Pain: Use of Alcohol and Pain Services
    NIH/NIAAA R21AA016326Aug 1, 2007 - Jul 31, 2010
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Ramo DE, Bahorik AL, Delucchi KL, Campbell C, Satre DD. Alcohol and Drug Use, Pain and Psychiatric Symptoms among Adults Seeking Outpatient Psychiatric Treatment: Latent Class Patterns and Relationship to Health Status. J Psychoactive Drugs. 2017 Dec 04; 1-11. PMID: 29199899.
      View in: PubMed
    2. Bahorik AL, Campbell C, Sterling SA, Leibowitz A, Travis A, Weisner CM, Satre DD. Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder. Psychiatry Res. 2017 Oct 19; 259:316-322. PMID: 29100135.
      View in: PubMed
    3. Young-Wolff KC, Klebaner D, Weisner C, Von Korff M, Campbell C. Smoking Status and Opioid-related Problems and Concerns Among Men and Women on Chronic Opioid Therapy. Clin J Pain. 2017 Aug; 33(8):730-737. PMID: 27898458.
      View in: PubMed
    4. Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Young-Wolff KC, Campbell C. Alcohol, marijuana, and opioid use disorders: 5-Year patterns and characteristics of emergency department encounters. Subst Abus. 2017 Jul 19; 1-10. PMID: 28723312.
      View in: PubMed
    5. Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Campbell C. Serious mental illness and medical comorbidities: Findings from an integrated health care system. J Psychosom Res. 2017 Sep; 100:35-45. PMID: 28789791.
      View in: PubMed
    6. Campbell C, Bahorik AL, Kline-Simon AH, Satre DD. The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study. Drug Alcohol Depend. 2017 Sep 01; 178:170-175. PMID: 28651153.
      View in: PubMed
    7. Young-Wolff KC, Klebaner D, Campbell C, Weisner C, Satre DD, Adams AS. Association of the Affordable Care Act With Smoking and Tobacco Treatment Utilization Among Adults Newly Enrolled in Health Care. Med Care. 2017 May; 55(5):535-541. PMID: 28288073.
      View in: PubMed
    8. Ray GT, Bahorik AL, VanVeldhuisen PC, Weisner CM, Rubinstein AL, Campbell C. Prescription opioid registry protocol in an integrated health system. Am J Manag Care. 2017 May 01; 23(5):e146-e155. PMID: 28810131.
      View in: PubMed
    9. Campbell C, Parthasarathy S, Young-Wolff KC, Satre DD. Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System. J Psychoactive Drugs. 2017 Apr-Jun; 49(2):160-168. PMID: 28426332.
      View in: PubMed
    10. Ray GT, Weisner CM, Taillac CJ, Campbell C. The high price of depression: Family members' health conditions and health care costs. Gen Hosp Psychiatry. 2017 May; 46:79-87. PMID: 28622822.
      View in: PubMed
    11. Campbell C, Kline-Simon AH, Von Korff M, Saunders KW, Weisner C. Alcohol and Drug Use and Aberrant Drug-Related Behavior Among Patients on Chronic Opioid Therapy. Subst Use Misuse. 2017 Aug 24; 52(10):1283-1291. PMID: 28346056.
      View in: PubMed
    12. Green CA, Perrin NA, Janoff SL, Campbell C, Chilcoat HD, Coplan PM. Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records. Pharmacoepidemiol Drug Saf. 2017 May; 26(5):509-517. PMID: 28074520.
      View in: PubMed
    13. Lui CK, Sterling SA, Chi FW, Lu Y, Campbell C. Socioeconomic differences in adolescent substance abuse treatment participation and long-term outcomes. Addict Behav. 2017 May; 68:45-51. PMID: 28088743.
      View in: PubMed
    14. Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Campbell C, et al. Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System. J Addict Med. 2017 Jan/Feb; 11(1):3-9. PMID: 27610582.
      View in: PubMed
    15. Satre DD, Altschuler A, Parthasarathy S, Silverberg MJ, Volberding P, Campbell C. Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics. J Acquir Immune Defic Syndr. 2016 Dec 15; 73(5):e76-e82. PMID: 27749602.
      View in: PubMed
    16. Campbell C, Sterling S, Chi FW, Kline-Simon AH. Marijuana use and service utilization among adolescents 7 years post substance use treatment. Drug Alcohol Depend. 2016 Nov 01; 168:1-7. PMID: 27606492.
      View in: PubMed
    17. Janoff SL, Perrin NA, Coplan PM, Chilcoat HD, Campbell C, Green CA. Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties. BMC Pharmacol Toxicol. 2016 May 14; 17(1):21. PMID: 27177423; PMCID: PMC4867981.
    18. Satre DD, Parthasarathy S, Altschuler A, Silverberg MJ, Storholm E, Campbell C. Demographic, Insurance, and Health Characteristics of Newly Enrolled HIV-Positive Patients After Implementation of the Affordable Care Act in California. Am J Public Health. 2016 Jul; 106(7):1211-3. PMID: 27077361; PMCID: PMC4902724 [Available on 07/01/17].
    19. Parthasarathy S, Campbell C. High-Deductible Health Plans: Implications for Substance Use Treatment. Health Serv Res. 2016 Oct; 51(5):1939-59. PMID: 26840191.
      View in: PubMed
    20. Mertens JR, Chi FW, Weisner CM, Satre DD, Ross TB, Allen S, Pating D, Campbell C, Lu YW, Sterling SA. Physician versus non-physician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: the ADVISe cluster randomized controlled implementation trial. Addict Sci Clin Pract. 2015 Nov 19; 10:26. PMID: 26585638; PMCID: PMC4653951.
    21. Thielke SM, Turner JA, Shortreed SM, Saunders K, Leresche L, Campbell C, Weisner CC, Korff MV. Do patient-perceived pros and cons of opioids predict sustained higher-dose use? Clin J Pain. 2014 Feb; 30(2):93-101. PMID: 23535150; PMCID: PMC3805783.
    22. Chi FW, Sterling S, Campbell C, Weisner C. 12-step participation and outcomes over 7 years among adolescent substance use patients with and without psychiatric comorbidity. Subst Abus. 2013; 34(1):33-42. PMID: 23327502; PMCID: PMC3558833.
    23. Merrill JO, Von Korff M, Banta-Green CJ, Sullivan MD, Saunders KW, Campbell C, Weisner C. Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients. Gen Hosp Psychiatry. 2012 Nov-Dec; 34(6):581-7. PMID: 22959422; PMCID: PMC3665511.
    24. Howe CQ, Sullivan MD, Saunders KW, Merrill JO, Banta-Green CJ, Weisner C, Campbell C, Von Korff M. Depression and ambivalence toward chronic opioid therapy for chronic noncancer pain. Clin J Pain. 2012 Sep; 28(7):561-6. PMID: 22699127; PMCID: PMC3414634.
    25. Grattan A, Sullivan MD, Saunders KW, Campbell C, Von Korff MR. Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann Fam Med. 2012 Jul-Aug; 10(4):304-11. PMID: 22778118; PMCID: PMC3392289.
    26. Mundt MP, Parthasarathy S, Chi FW, Sterling S, Campbell C. 12-Step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug Alcohol Depend. 2012 Nov 01; 126(1-2):124-30. PMID: 22633367; PMCID: PMC3430743.
    27. Chi FW, Campbell C, Sterling S, Weisner C. Twelve-Step attendance trajectories over 7 years among adolescents entering substance use treatment in an integrated health plan. Addiction. 2012 May; 107(5):933-42. PMID: 22151625; PMCID: PMC3311783.
    28. Saunders KW, Von Korff M, Campbell C, Banta-Green CJ, Sullivan MD, Merrill JO, Weisner C. Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain. 2012 Mar; 13(3):266-75. PMID: 22285611; PMCID: PMC3294025.
    29. Silverberg MJ, Ray GT, Saunders K, Rutter CM, Campbell C, Merrill JO, Sullivan MD, Banta-Green CJ, Von Korff M, Weisner C. Prescription long-term opioid use in HIV-infected patients. Clin J Pain. 2012 Jan; 28(1):39-46. PMID: 21677568; PMCID: PMC3175344.
    30. Von Korff M, Merrill JO, Rutter CM, Sullivan M, Campbell C, Weisner C. Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain. 2011 Jun; 152(6):1256-62. PMID: 21296498; PMCID: PMC3098951.
    31. Campbell C, Weisner C, Leresche L, Ray GT, Saunders K, Sullivan MD, Banta-Green CJ, Merrill JO, Silverberg MJ, Boudreau D, Satre DD, Von Korff M. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health. 2010 Dec; 100(12):2541-7. PMID: 20724688; PMCID: PMC2978198.
    32. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell C, Psaty BM, Von Korff M. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010 Jan 19; 152(2):85-92. PMID: 20083827; PMCID: PMC3000551.
    33. Satre DD, Campbell C, Gordon NS, Weisner C. Ethnic disparities in accessing treatment for depression and substance use disorders in an integrated health plan. Int J Psychiatry Med. 2010; 40(1):57-76. PMID: 20565045; PMCID: PMC2922921.
    34. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell C, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009 Dec; 18(12):1166-75. PMID: 19718704; PMCID: PMC3280087.
    35. Weisner CM, Campbell C, Ray GT, Saunders K, Merrill JO, Banta-Green C, Sullivan MD, Silverberg MJ, Mertens JR, Boudreau D, Von Korff M. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain. 2009 Oct; 145(3):287-93. PMID: 19581051; PMCID: PMC2929845.
    36. Chi FW, Kaskutas LA, Sterling S, Campbell C, Weisner C. Twelve-Step affiliation and 3-year substance use outcomes among adolescents: social support and religious service attendance as potential mediators. Addiction. 2009 Jun; 104(6):927-39. PMID: 19344442; PMCID: PMC2722376.
    37. Campbell C, Alexander JA, Lemak CH. Organizational determinants of outpatient substance abuse treatment duration in women. J Subst Abuse Treat. 2009 Jul; 37(1):64-72. PMID: 19038526; PMCID: PMC2935286.
    38. Campbell C, Chi F, Sterling S, Kohn C, Weisner C. Self-initiated tobacco cessation and substance use outcomes among adolescents entering substance use treatment in a managed care organization. Addict Behav. 2009 Feb; 34(2):171-9. PMID: 19010600; PMCID: PMC2700774.
    39. Campbell C, Wells R, Alexander JA, Jiang L, Nahra TA, Lemak CH. Tailoring of outpatient substance abuse treatment to women, 1995-2005. Med Care. 2007 Aug; 45(8):775-80. PMID: 17667312.
      View in: PubMed
    40. Alexander JA, Nahra TA, Lemak CH, Pollack H, Campbell C. Tailored treatment in the outpatient substance abuse treatment sector: 1995-2005. J Subst Abuse Treat. 2008 Apr; 34(3):282-92. PMID: 17600653.
      View in: PubMed
    41. Wells R, Lemak CH, Alexander JA, Nahra TA, Ye Y, Campbell C. Do licensing and accreditation matter in outpatient substance abuse treatment programs? J Subst Abuse Treat. 2007 Jul; 33(1):43-50. PMID: 17588488.
      View in: PubMed
    42. Campbell C, Weisner C, Sterling S. Adolescents entering chemical dependency treatment in private managed care: ethnic differences in treatment initiation and retention. J Adolesc Health. 2006 Apr; 38(4):343-50. PMID: 16549294.
      View in: PubMed
    43. Campbell C, Alexander JA. Availability of services for women in outpatient substance abuse treatment: 1995-2000. J Behav Health Serv Res. 2006 Jan; 33(1):1-19. PMID: 16636905.
      View in: PubMed
    44. Campbell C, Alexander JA. Health services for women in outpatient substance abuse treatment. Health Serv Res. 2005 Jun; 40(3):781-810. PMID: 15960691; PMCID: PMC1361168.
    45. Alexander JA, Lemak CH, Campbell C. Changes in managed care activity in outpatient substance abuse treatment organizations, 1995-2000. J Behav Health Serv Res. 2003 Oct-Dec; 30(4):369-81. PMID: 14593661.
      View in: PubMed
    46. Campbell C, Alexander JA. Culturally competent treatment practices and ancillary service use in outpatient substance abuse treatment. J Subst Abuse Treat. 2002 Apr; 22(3):109-19. PMID: 12039613.
      View in: PubMed
    Back to TOP